Literature DB >> 3914623

A double blind placebo controlled trial of ascorbic acid in obesity.

G J Naylor, L Grant, C Smith.   

Abstract

A double blind placebo controlled trial of ascorbic acid was carried out in 41 severely obese subjects. 38 patients completed the 6 week trial. 19 received 3g of ascorbic acid per day, 19 received placebo. The weight loss during the trial was small in both groups but was significantly greater in the ascorbic acid treated group.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3914623     DOI： 10.1177/026010618500400104

Source DB:  PubMed          Journal:  Nutr Health        ISSN： 0260-1060


  3 in total

1.  Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.

Authors:  Hyunghee Lee; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Int J Obes (Lond)       Date:  2018-10-03       Impact factor: 5.095

2.  Dietary ascorbic acid and subsequent change in body weight and waist circumference: associations may depend on genetic predisposition to obesity--a prospective study of three independent cohorts.

Authors:  Sofus C Larsen; Lars Angquist; Tarunveer Singh Ahluwalia; Tea Skaaby; Nina Roswall; Anne Tjønneland; Jytte Halkjær; Kim Overvad; Oluf Pedersen; Torben Hansen; Allan Linneberg; Lise Lotte N Husemoen; Ulla Toft; Berit L Heitmann; Thorkild I A Sørensen
Journal:  Nutr J       Date:  2014-05-03       Impact factor: 3.271

3.  Adipogenic and Lipolytic Effects of Ascorbic Acid in Ovariectomized Rats.

Authors:  Byoungjae Kim; Kyung Min Choi; Hong Soon Yim; Hyun Tae Park; Joung Han Yim; Min Goo Lee
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.